Table 2.
Main genes that were up- or downregulated based on the GO analysis at week 4 compared with the levels of expression in the control.
| Upregulated genes | Downregulated genes | ||||
|---|---|---|---|---|---|
| GO category | Numbers of genes | P value | GO category | Numbers of genes | P value |
| Cellular component | |||||
| Extracellular matrix | 27 | <0.0001 | Basolateral plasma membrane | 12 | 0.0001 |
| Extracellular region | 55 | <0.0001 | Cell surface | 27 | 0.0002 |
| Extracellular space | 50 | <0.0001 | Cell-cell junction | 13 | 0.0001 |
| Ribosome | 38 | <0.0001 | Glutamate-cysteine ligase complex | 2 | <0.0001 |
| Keratin filament | 8 | <0.0001 | |||
|
| |||||
| Biological process | |||||
| Angiogenesis | 16 | 0.0002 | Chaperone mediated protein folding requiring cofactor | 5 | <0.0001 |
| Bone mineralization | 6 | 0.0002 | Desmosome organization | 2 | <0.0001 |
| Cartilage morphogenesis | 3 | <0.0001 | Glutathione metabolic process | 8 | <0.0001 |
| Heterophilic cell-cell adhesion | 5 | 0.0003 | Glycerol-3-phosphate metabolic process | 3 | <0.0001 |
| Intramembranous ossification | 3 | 0.0001 | Male sex differentiation | 2 | <0.0001 |
| Negative regulation of mesodermal cell fate specification | 3 | <0.0001 | Neutrophil aggregation | 2 | <0.0001 |
| Regulation of stem cell division | 2 | <0.0001 | Oxidation-reduction process | 49 | <0.0001 |
| Stem cell fate specification | 2 | <0.0001 | Smooth muscle cell migration | 2 | <0.0001 |
| Translation | 40 | <0.0001 | Superoxide metabolic process | 5 | 0.0001 |
| Termination of signal transduction | 2 | <0.0001 | |||
| Ventricular system development | 4 | 0.0001 | |||
|
| |||||
| Molecular function | |||||
| Ceramide kinase activity | 2 | <0.0001 | Catalytic activity | 52 | <0.0001 |
| Extracellular matrix binding | 6 | <0.0001 | Chemokine binding | 2 | <0.0001 |
| Retinoid binding | 3 | <0.0001 | Glutamate-cysteine ligase activity | 2 | <0.0001 |
| Structural constituent of ribosome | 37 | <0.0001 | Glycerol channel activity | 2 | <0.0001 |
| Interleukin-8 binding | 2 | <0.0001 | |||
| NAD binding | 9 | <0.0001 | |||
| Oxidoreductase activity | 44 | <0.0001 | |||
| Oxidoreductase activity, acting on CH-OH group of donors | 5 | <0.0001 | |||
| Oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 7 | 0.0001 | |||
| Structural molecule activity | 18 | <0.0001 | |||
| UDP-N-acetylmuramate dehydrogenase activity | 4 | 0.0001 | |||
The values were compared according to fold change.